Public source

Reviewed 11 May 2026

Completeness Fair (36%)

aBSI

EXINI

An AI-enabled software for quantitative assessment of bone scans. The system detects and marks hotspots and automatically calculates the Bone Scan Index (BSI), representing total skeletal tumor burden.

No papers to support — we monitor for new evidence.

Key features

Bone Scan Index (BSI)

Quantative assessment of bone scans

Tumor burden

General Information

Product name

aBSI

Company

Modality

SPECT

Main task

Detection, Quantification

Subspeciality

MSK

Disease targeted

Bone metastases

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Not verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

FDA Number:

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Mar 31, 2026 | Last updated: May 11, 2026